Indic Leadership Forum Inc.
Focus Area

Biotech, MedTech & Digital Health

Indian-origin scientists and clinicians are at the forefront of AI-driven drug discovery, FDA-navigated MedTech, and the digital health platforms transforming global healthcare.

$45B

AI drug discovery market projected by 2030

3.5x

Faster clinical trial enrollment using AI-powered patient matching

NC

Life science companies in Research Triangle Park, one of the top US biotech clusters
The Moment We are In

AI and life sciences are converging faster than regulation can track

AI is reshaping how drugs are discovered, how clinical trials are run, and how care is delivered and Indian-origin scientists and engineers are disproportionately represented at the frontier of this convergence, from computational biology to FDA submission strategy to digital therapeutics. RTP's life-science cluster, anchored by biotech companies, NIEHS, and three world-class research universities, makes it an ideal home for ILF's Biotech & MedTech working group.

Biotech & MedTech — Express Your Interest

We are shaping this pillar community now. Express your interest and help set the agenda.
                                   Express Interest in This Pillar                                   

→ How do Indian-origin biotech founders navigate the FDA pathway from discovery to approval, and where does the community need stronger support?

→ What does responsible AI in clinical decision support actually look like, and who is setting the standards?

→ As AI compresses trial timelines, what new governance questions does that speed create for patient safety?

What We are Tracking

Sub-topics inside this pillar

Discovery

AI-driven drug discovery

Computational biology and generative models compressing early-stage discovery timelines — and what that means for the founders building in this space.

Regulatory

FDA pathway & MedTech approval

Navigating discovery-to-approval for AI-enabled devices and diagnostics, and where Indian-origin founders are building playbooks worth sharing.

Digital Health

Digital therapeutics & care delivery

How digital health platforms are reaching patients directly, and what responsible deployment looks like at scale.

Working in this space?

We're looking for scientists, founders, and practitioners to write an anchor essay or join ILF Conversations for this pillar.
Express Interest

Frugal Bio-based Approaches to Global Healthcare

By Dr. Dhanush Jamadgni, Postdoctoral researcher - NC State University

An estimated 4 billion people worldwide still lack access to essential healthcare, and untreated visceral leishmaniasis is fatal in more than 90 percent of cases. A frugal-innovation case study on how sugarcane waste discarded across Mauritius is becoming a low-cost wound patch for the communities conventional medicine can't reach.
Download the Article